DONATE

Views Navigation

Event Views Navigation

Today

PhD Thesis Defense: Anna Vila Giraut

Hydrogel co-networks of gelatin methacryloyl and poly(ethylene glycol)diacrylate sustain 3D functional in vitro models of intestinal mucosa Anna Vila Giraut, Biomimetic systems for cell engineering Group Conventional in vitro cell culture models do not possess the complexity that the native tissues offer. Because of this, the functional properties of the tissues are not properly mimicked, which ... Read more

PhD Discussions Sessions: Nimesh Ramesh and Sock Ching Low

Microfluidic device for engineering 3D epithelial monolayers with controlled pressure Nimesh Ramesh, Integrative Cell and Tissue Dynamics The remarkable feature of the epithelial sheets is to form specialized 3D structures suited to their physiological roles, such as highly branched structures in the lungs, drastic shape changes during embryonic development, or self-organizing organoids. These tissues are ... Read more

PhD Thesis Defense: Elena Lantero

Targeting strategies against Plasmodium and practical applications: blocking parasite development with heparin derivatives and identifying new aptamers for diagnosis Elena Lantero, Nanomalaria Group This thesis defense will take place ONLINE on the 11th December at 14.00 using the “BB Collaborate” streaming platform.

PhD Thesis Defense: Sock Ching Low

Giving Centre Stage to Top-Down Inhibitory Mechanisms for Selective Attention Sock Ching Low, SPECS (Synthetic, Perceptive, Emotive and Cognitive Systems) Selective attention determines the sensory signals that are processed at higher levels at the expense of others and is biased by higher-order brain regions which anticipate task-relevant stimuli and increase neural sensitivity to them in ... Read more

PhD Thesis Defense: Laia Lidón Gil

Regulación de la expresión de PrPC como elemento clave en las modificaciones de tau en la enfermedad de Alzheimer Laia Lidón, Molecular and Cellular Neurobiotechnology La enfermedad de Alzheimer (EA) es la causa más común de demencia y tiene una elevada prevalencia a nivel mundial. Se caracteriza por un deterioro cognitivo progresivo y muestra como ... Read more

Online IBEC Seminar: Silvia Muro

Targeted drug delivery: fundamental aspects and translational applications Silvia Muro, IBEC The design of strategies to enable efficient and safe delivery of therapeutic agents to areas of the body requiring intervention is an active research field. Therapeutic targets are often confined to specific regions or tissues in the body, where access may require active transport ... Read more

PhD Thesis Defense: Maria Blancas Muñoz

Knowing what you know. A pedagogical model based on learners' metacognitive abilities Maria Blancas Muñoz, Synthetic, Perceptive, Emotive and Cognitive Systems (SPECS) This thesis defense will be held online next 15th January at 11, via "zoom", using this link.

PhD Discussions Sessions: Gerard Rubí and Ignasi Ferrer

Development of an in vitro three-dimensional colorectal tumor model for drug screening Gerard Rubí, Biomaterials for Regenerative Therapies The majority of morphogenetic and pathological processes are driven by cells responding to the surrounding matrix cues, including matrix composition, architecture, and mechanical properties. Despite the increased evidence of extracellular matrix (ECM) properties, in vitro substitutes still ... Read more

Nanodía Mundial Contra el Cáncer

El Nanodía Mundial Contra el Cáncer es un evento organizado en el marco del Día Mundial contra el Cáncer donde se darán a conocer las últimas innovaciones en materia de NANOMEDICINA contra el CÁNCER, con temas que van desde el diagnóstico precoz, la liberación controlada de fármacos o la radioterapia con nanopartículas. Un año más, expertos en NANOMEDICINA de diferentes ... Read more

Online IBEC Seminar: Jordi Alcaraz

Improving lung cancer management by reengineering tumor-associated fibroblasts Jordi Alcaraz, UB facultat de Medicina & IBEC Associated Researcher Lung cancer is the leading cause of cancer death due in part to subtoptimal patient responses to current therapies, which have been largely designed to targeting cancer cell abnormalities. However, there is a paradigm shift in cancer ... Read more